Goldman Sachs’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-25,000
Closed -$3.5M 5876
2020
Q3
$3.5M Sell
25,000
-10,000
-29% -$1.22M ﹤0.01% 3168
2020
Q2
$2.63M Buy
+35,000
New +$1.83M ﹤0.01% 3264

Goldman Sachs's LVGO Position: Q4 2020 in Review

Goldman Sachs sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 1,242,346 shares — an estimated $174M sold.

Goldman Sachs first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $174M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • Goldman Sachs reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Goldman Sachs sold 1,242,346 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $174M.
  • Goldman Sachs first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
  • Goldman Sachs's Livongo Health, Inc. Common Stock position peaked at $174M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.